159 related articles for article (PubMed ID: 2484433)
1. Interferon therapy for lymphoproliferative disorders.
Roth MS; Bunn PA; Foon KA
Cancer Treat Res; 1988; 38():231-52. PubMed ID: 2484433
[No Abstract] [Full Text] [Related]
2. Biological molecules in the treatment of hematological disorders.
Kurzrock R; Talpaz M; Gutterman U
Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
[No Abstract] [Full Text] [Related]
3. Recombinant alpha-interferons, thyroid irradiation and thyroid disease.
Giles FJ; Worman CP; Jewell AP; Goldstone AH
Acta Haematol; 1991; 85(3):160-3. PubMed ID: 1904180
[TBL] [Abstract][Full Text] [Related]
4. Biotherapy of chronic myelogenous leukemia with interferon.
Ozer H
Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
[No Abstract] [Full Text] [Related]
5. [Interferon and chronic myeloid leukemia].
Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM
Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124
[No Abstract] [Full Text] [Related]
6. A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
Reiter Z; Ozes ON; Tomson S; Blatt LM; Taylor MW
Adv Exp Med Biol; 1991; 309A():69-73. PubMed ID: 1686352
[No Abstract] [Full Text] [Related]
7. The anti-tumor activities of interferon (IFN)-alpha in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-alpha subtypes.
Yanai Y; Sanou O; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
Cancer Lett; 2002 Nov; 185(2):173-9. PubMed ID: 12169391
[TBL] [Abstract][Full Text] [Related]
8. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
[TBL] [Abstract][Full Text] [Related]
9. alpha-Interferon in hematological malignancies.
Giles FJ; Ozer H
Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
[TBL] [Abstract][Full Text] [Related]
10. Interferons for the treatment of hematological malignancies.
Urabe A
Oncology; 1994; 51(2):137-41. PubMed ID: 7515169
[TBL] [Abstract][Full Text] [Related]
11. Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia.
Preisler HD; Raza A; Baccarani M
Leuk Lymphoma; 1993; 11 Suppl 1():303-6. PubMed ID: 7504547
[TBL] [Abstract][Full Text] [Related]
12. Therapy with interferons in blood diseases.
Polli E; Cortelezzi A
Acta Haematol; 1987; 78 Suppl 1():64-9. PubMed ID: 2449025
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis.
Santucci MA; Soligo D; Pileri S; Zuffa E; Testoni N; Tura S
Leuk Lymphoma; 1993; 11 Suppl 1():113-8. PubMed ID: 8251886
[No Abstract] [Full Text] [Related]
14. [Essential thrombocythemia: therapy with alpha interferons].
Gugliotta L; Catani L; Vianelli N; Mattioli Belmonte M; Cascione ML; Bendani M; Fanin R; Michieli MG; Baccarani M; Tura S
Haematologica; 1991 Jun; 76 Suppl 3():374-7. PubMed ID: 1752536
[No Abstract] [Full Text] [Related]
15. Interferon therapy of hematologic malignancies.
Foon KA
Cancer Treat Res; 1998; 94():1-21. PubMed ID: 9587679
[No Abstract] [Full Text] [Related]
16. Activity of alpha-interferons in chronic myelogenous leukaemia.
Talpaz M
Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
[No Abstract] [Full Text] [Related]
17. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
[No Abstract] [Full Text] [Related]
18. Interferon: a perspective.
Weissman RM; Droller MJ
Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
[No Abstract] [Full Text] [Related]
19. Effect of recombinant human interferons on NK and K cell activities of gnotobiotic miniature swine.
Kim YB; Chung TJ
Prog Clin Biol Res; 1985; 181():329-32. PubMed ID: 3927308
[No Abstract] [Full Text] [Related]
20. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
Guilhot F
Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
